Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
6472 NTN
- 254.7
- -0.1-0.04%
20min DelayMarket Closed Dec 30 15:30 JST
135.62BMarket Cap13.66P/E (Static)
255.3High252.7Low3.10MVolume254.0Open254.8Pre Close787.78MTurnover338.452wk High0.69%Turnover Ratio532.46MShares230.152wk Low7.01EPS TTM114.91BFloat Cap949.0Historical High13.66P/E (Static)451.15MShs Float131.0Historical Low18.65EPS LYR1.02%Amplitude10.50Dividend TTM0.53P/B100Lot Size4.12%Div YieldTTM
NTN Key Stats
Quarterly+Annual
YOY
| (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.00%210.81B | 8.05%836.29B | 5.48%215.74B | 6.66%210.9B | 4.92%208.88B | 16.31%200.77B | 20.55%773.96B | 17.62%204.54B | 21.80%197.72B | 33.46%199.09B |
| Cost of revenue | 3.06%175.69B | 6.63%691.01B | 1.28%173.46B | 5.30%172.37B | 4.78%174.71B | 16.48%170.47B | 20.89%648.05B | 18.40%171.26B | 19.84%163.7B | 33.71%166.75B |
| Gross profit | 15.91%35.12B | 15.38%145.28B | 27.06%42.28B | 13.23%38.53B | 5.65%34.17B | 15.35%30.3B | 18.84%125.91B | 13.77%33.28B | 32.22%34.03B | 32.19%32.34B |
| Operating expense | 6.17%30.59B | 7.69%117.13B | 13.47%29.53B | 6.80%29.9B | 4.32%28.9B | 6.49%28.81B | 9.78%108.77B | 4.46%26.02B | 12.88%27.99B | 12.99%27.7B |
| Operating profit | 204.23%4.53B | 64.17%28.15B | 75.81%12.76B | 43.09%8.63B | 13.57%5.27B | 290.05%1.49B | 149.18%17.15B | 67.20%7.26B | 545.72%6.03B | 9,980.85%4.64B |
| Net non-operating interest income (expenses) | -15.20%-1.82B | -49.06%-7.1B | -58.68%-1.9B | -31.72%-1.94B | -42.28%-1.69B | -73.14%-1.58B | -39.67%-4.76B | -45.21%-1.2B | -76.14%-1.47B | -35.43%-1.19B |
| Non-operating interest income | 61.17%498M | 23.73%1.42B | 24.25%374M | -27.57%310M | 165.63%425M | 20.23%309M | 32.33%1.15B | 38.07%301M | 100.94%428M | -27.93%160M |
| Non-operating interest expense | 22.72%2.32B | 44.15%8.52B | 51.77%2.28B | 18.34%2.25B | 56.95%2.11B | 61.51%1.89B | 38.18%5.91B | 43.72%1.5B | 81.18%1.9B | 22.61%1.35B |
| Net investment income | -109.31%-363M | 141.42%1.28B | 142.37%2.65B | 36.59%-3.63B | -72.50%-1.64B | 57.07%3.9B | -197.00%-3.1B | -63.04%1.1B | -1,960.06%-5.73B | -80.76%-949M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | 35.25%-1.27B | 1.27B | 1.91B | -29.22%-1.91B | 350.62%2.04B | -141.75%-1.96B | |||
| Gain(Loss) on derecognition of available-for-sale financial assets | 690M | 169M | 0 | 0 | ||||||
| Income from associates and other participating interests | 3.03%170M | -66.69%486M | -97.87%3M | -77.06%139M | -23.83%179M | -65.41%165M | 32.76%1.46B | -18.97%141M | 41.59%606M | -18.97%235M |
| Special income (charges) | -233.60%-4.14B | -1,430.60%-4.85B | 220.78%1.12B | -486.60%-1.24B | 42.78%-317M | -194.96%-924M | ||||
| Less:Restructuring and mergern&acquisition | ---- | 131.38%3.12B | 440.33%2.29B | -54.11%424M | ---- | ---- | --1.35B | --424M | --924M | ---- |
| Less:Other special charges | ---- | -83.39%-3.15B | ---1.61B | ---- | ---- | ---- | -86.12%-1.72B | ---- | ---- | ---- |
| Less:Write off | ---- | 159.04%4.17B | ---- | ---- | ---- | ---- | 167.72%1.61B | ---- | ---- | ---- |
| Other non-operating income (expenses) | -119.05%-322M | -286.56%-2.82B | -191.76%-2.02B | 11.81%426M | -68.70%-1.08B | -166.52%-147M | -428.26%-729M | 13.82%-692M | 92.42%381M | -602.20%-639M |
| Income before tax | 14.29%2.2B | 53.15%16.55B | 28.14%5.54B | 125.92%6.54B | -28.75%2.55B | 19,150.00%1.93B | -38.66%10.81B | -71.13%4.32B | 175.79%2.89B | 476.76%3.58B |
| Income tax | 2,747.69%1.72B | 515.84%4.38B | 133.10%2.33B | 53.78%2.46B | -116.07%-348M | -102.91%-65M | -112.37%-1.05B | -223.01%-7.05B | 76.32%1.6B | 139.60%2.17B |
| Net income | -75.99%478M | 2.59%12.17B | -71.84%3.2B | 215.33%4.07B | 104.80%2.9B | 189.68%1.99B | 30.40%11.86B | 23.18%11.37B | 822.86%1.29B | 176.38%1.42B |
| Net income continuous operations | -75.93%479M | 2.59%12.17B | -71.84%3.2B | 215.33%4.07B | 104.73%2.9B | 189.60%1.99B | 30.38%11.86B | 23.16%11.37B | 816.31%1.29B | 176.39%1.42B |
| Noncontrolling interests | -12.29%307M | 7.10%1.6B | 25.90%316M | 24.94%516M | -25.93%417M | 31.58%350M | -14.93%1.49B | -34.81%251M | -31.17%413M | 48.94%563M |
| Net income attributable to the company | -89.64%170M | 1.94%10.57B | -74.05%2.89B | 304.78%3.56B | 190.75%2.48B | 165.98%1.64B | 41.22%10.37B | 25.68%11.12B | 291.09%879M | 138.26%854M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -89.64%170M | 1.94%10.57B | -74.05%2.89B | 304.78%3.56B | 190.75%2.48B | 165.98%1.64B | 41.22%10.37B | 25.68%11.12B | 291.09%879M | 138.26%854M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -89.64%0.32 | 1.95%19.91 | -74.03%5.44 | 303.61%6.7 | 190.68%4.68 | 165.88%3.09 | 41.21%19.53 | 25.67%20.95 | 290.80%1.66 | 138.33%1.61 |
| Diluted earnings per share | -91.26%0.27 | -4.51%18.65 | -76.75%4.87 | 271.42%6.15 | 190.73%4.677 | 165.88%3.09 | 41.21%19.53 | 25.67%20.9476 | 290.32%1.6558 | 138.28%1.6087 |
| Dividend per share | 0 | 100.00%10 | 100.00%5 | 0 | 100.00%5 | 0 | 5 | 2.5 | 0 | 2.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |